SBC Medical Group

SBC | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.14

+$0.39 (+8.21%)

At close: Sep 21, 2026, 4:00 PM ET

$5.24

+$0.10 (+1.95%)

Pre-market: Sep 22, 2026, 4:43 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $488.52M

Enterprise Value $366.62M

Beta 0.63

Average Volume 139.42K

Shares Outstanding (Diluted) 102.58M

Shares Change YoY -0.9%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US73245B1070

Price Performance

Price Change 1M 26.6%

Price Change 3M 67.4%

Price Change 6M 34.9%

Price Change YTD 18.7%

Price Change 1Y 14.7%

Price Change 3Y -51.8%

Price Change 5Y -48.7%

1M CAGR (ann.) 59.9%

1Y CAGR (ann.) 4.2%

5Y CAGR (ann.) N/A

All-Time CAGR -17.0%

Valuation

PE Ratio 10.94

Forward PE 8.78

PEG Ratio 0.24

Forward PEG 0.71

PS Ratio 3.02

Forward PS 2.60

PB Ratio 1.89

P/FCF Ratio 7.05

P/Adj. FCF Ratio 7.05

P/OCF Ratio 6.85

EV/Sales 2.09

EV/EBIT 4.93

EV/EBITDA 4.80

EV/FCF 4.89

Earnings Yield 9.1%

FCF Yield 14.2%

Adj. FCF Yield 14.2%

Financial Health

Net Cash $162.02M

Total Debt $22.29M

Cash & Short-Term Investments $184.31M

Total Assets $406.66M

Current Ratio 3.31

Quick Ratio 3.27

Debt / Equity Ratio 0.18

Debt / EBITDA 0.29

Debt / FCF 0.30

OCF / Debt 3.46

Interest Coverage 187.88

Altman Z-Score 3.88

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 71.3%

Operating Profit Margin 37.3%

EBITDA Margin 43.6%

Net Profit Margin 28.0%

FCF Margin 42.8%

Adj. FCF Margin 42.8%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets 12.1%

Return on Equity 19.3%

Return on Invested Capital 12.6%

Return on Capital Employed 19.9%

Return on Tangible Assets 14.2%

Historical Growth (CAGR)

Revenue CAGR 3Y 27.8%

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 97.1%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y 12.6%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $5.37

Graham Upside 4.5%

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $12

Price Target Upside 133.5%

Cash Flow

Operating Cash Flow $77.07M

Free Cash Flow $74.96M

Adj. Free Cash Flow $74.96M

FCF Per Share $0.73

OCF Per Share $0.75

OCF/S Ratio 44.0%

Income Statement

Revenue $175.17M

Gross Profit $124.84M

Operating Income $65.41M

EBITDA $76.46M

Net Income $49.03M

EPS (Diluted) $0.47

Revenue / Employee $202.98K

Profit / Employee $56.81K

Employees 863